Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.
about
Allele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian PopulationGenetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patientsCYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.Mutational landscape of candidate genes in familial prostate cancerPopulation differences in the frequency of the agouti signaling protein g.8818a>G polymorphism.Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomesFrequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemiaA49T, R227Q and TA repeat polymorphism of steroid 5 alpha-reductase type II gene and Hypospadias risk in North Indian children.Decision tree-based modeling of androgen pathway genes and prostate cancer riskPharmacogenetics in Ghana: reviewing the evidence.Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Assessing the function of genetic variants in candidate gene association studies.Distribution of human CYP2C8*2 allele in three different African populationsSRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.Relationship of early-onset baldness to prostate cancer in African-American men.A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profileMolecular mechanisms involving prostate cancer racial disparity.Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.Cytochrome P450 pharmacogenetics in African populations.The new insight of prostate-specific antigen reduction during finasteride therapy in aging men.Molecular basis for prostate cancer racial disparities.Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese MenJoint effects of inflammation and androgen metabolism on prostate cancer severity.A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta.Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Within-group differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices.Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH.Pharmacogenetically relevant polymorphisms in Portugal.Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve.CYP3A4*1B and NAT2*14 alleles in a native African population.Social determinants of prostate cancer in the Caribbean: a systematic review and meta-analysisProstate cancer in the Arab population. An overview
P2860
Q28397131-DA96D464-BD9A-421B-A5C4-90198C3C279FQ33289676-938E7BE6-E990-4AF9-BC90-CC5B9B8095CBQ33632608-BDEAB1BB-7539-4568-85CF-805B3167E929Q33749037-700B9ED5-D30B-48BC-AA37-87513B66DCC8Q33888862-A0DCC80E-9EC1-4162-973E-299BF792A652Q34079517-9BCB827A-31E8-4386-BB13-838642B233F7Q34305155-22460123-70D4-4F48-AB57-32364A85CDC7Q34491448-C7428B79-5E71-4469-AFDB-5372C89670E4Q34722941-9A4985FC-7688-4FB2-BE30-4FF68E567DD4Q34951945-887B9F51-0D54-4CE9-904E-0318D4C7FAC2Q35022477-71ECFFAA-0D5F-4A93-A024-DCFA225F7E63Q35036697-8D7D0459-DC07-4EC6-A85A-B89DEA24B40FQ35172002-E3F0EBDD-1D86-4E34-B9BC-B0DE2AC8568AQ35584999-61D50FA7-F454-4EB8-81E1-DF09070B3A10Q35842159-1245509F-A653-467B-8E00-950601D89400Q35963368-DCE78DAF-2840-465C-BC6D-304AB9652524Q36254416-574B1130-D68D-45EF-AFB9-D2A270B726ADQ36741660-BD40C7CF-1C2F-4E62-9C71-CDC0D9D50E48Q36930090-31D143CD-6022-44A9-BAB6-0531111EB58BQ37063883-BD4DC50E-A936-4573-A13B-D286A21688E5Q37418937-C3D57D22-E994-4BE9-8B3F-843A08604A1FQ37633264-0714653C-F68F-402E-9B7A-07C6CF4DB005Q37818297-697D845D-0B2E-4E39-AA31-2E8163DDF2B9Q37939200-F6412079-D0BF-4E5D-A2B1-C1C4150E7162Q38099372-66452476-D312-40D4-BD77-5A0CCF14BB7AQ40120927-C47470D8-1EC6-4ED3-9E32-592090007EE5Q41334556-96F8A6A6-90A6-45B8-810B-B0EE1A44F545Q41564129-A5DAE6C9-D0F2-4C99-A44B-A86431811261Q41884768-41C76E94-5CF7-4395-BA41-3943C786F75CQ41931088-8C1BD46C-C983-4E4C-9F43-143E4825938AQ42113738-72F6FC9C-1541-4296-BC25-BCDFD727ACF3Q42634060-0AD9AE49-243F-43C1-BB1F-FE603069600DQ44502093-1B3C20A9-B43B-4D13-B659-F510DF35857FQ46173799-AEC9B983-BF1E-4FE0-B268-769CDA1AFABAQ46350332-5F96BE21-7EE3-4145-8150-5194F5FD1F6EQ46778374-2BA9DE22-8708-49D4-908B-97544755C597Q46825226-C926D8AA-039E-43DD-8F2C-4A4A1C685AE1Q54773493-FBF2CAAC-8ACA-4421-B159-CF3C196E84DFQ57093310-AD87D831-185F-4D0F-A2FA-AFDAC3405985Q57113351-B342AE45-6027-4993-A755-BA65BF7E32AF
P2860
Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Ethnic differences in the freq ...... alleles at SRD5A2 and CYP3A4.
@en
type
label
Ethnic differences in the freq ...... alleles at SRD5A2 and CYP3A4.
@en
prefLabel
Ethnic differences in the freq ...... alleles at SRD5A2 and CYP3A4.
@en
P2093
P356
P1433
P1476
Ethnic differences in the freq ...... alleles at SRD5A2 and CYP3A4.
@en
P2093
Malkowicz SB
Ofori-Adjei D
Rebbeck TR
Spangler E
P356
10.1159/000066695
P577
2002-01-01T00:00:00Z